Community Healthcare Trust (CHCT) Q1 2026: $99M Pipeline Targets 9% Yields as Portfolio Pruning Accelerates

CHCT’s Q1 marked a decisive pivot toward capital recycling and disciplined portfolio upgrades, with management signaling a robust $99 million pipeline of new acquisitions at attractive yields. Occupancy dipped and asset sales continued, but the company’s focus on long-term tenant quality, redevelopment, and self-funded growth positions it for improved cash flow in the back half of 2026. Management’s measured tone on acquisition pace and capital allocation signals a strategy of quality over quantity as sector competition intensifies.

Summary

  • Capital Recycling Drives Portfolio Quality: CHCT is actively selling underperforming assets to fund higher-yield acquisitions and redevelopment.
  • Acquisition Pipeline Anchored by High Cash Yields: $99 million of pending deals target 9%+ initial returns with 2% escalators.
  • Occupancy Pressures Offset by Redevelopment and Leasing: Management expects leased occupancy to rebound as new projects come online.

Business Overview

Community Healthcare Trust (CHCT) is a healthcare-focused real estate investment trust (REIT) that owns and acquires healthcare properties across the United States. CHCT generates revenue primarily through long-term triple-net leases, meaning tenants pay rent plus property expenses, on assets such as medical office buildings, inpatient rehabilitation facilities, and behavioral health centers. Major segments include stabilized rental properties, redevelopment projects, and a growing pipeline of newly constructed healthcare facilities.

Performance Analysis

Revenue increased 4.8% year over year, driven by recent acquisitions and higher recoveries of property operating expenses, partially offset by asset sales and lease terminations. The company’s occupancy rate slipped to 89.8% from 90.6%, with management attributing the dip to specific lease terminations and emphasizing the active leasing pipeline for the coming quarters. Weighted average lease term improved slightly to 7.1 years, reflecting a focus on securing long-term tenant commitments.

Property operating expenses rose due to seasonal factors, notably higher winter utilities and snow removal, while general and administrative expense was flat year over year but up sequentially due to typical first-quarter compensation and benefit timing. Interest expense declined modestly, but is expected to rise in Q2 as hedges expire and new debt supports acquisitions. Funds from operations (FFO) and adjusted FFO (AFFO) both posted low- to mid-single digit growth, supported by disciplined expense management and incremental rental income from new investments.

  • Redevelopment Initiatives: Three properties are under significant renovation, with the largest behavioral health facility expected to begin contributing NOI in Q3 2026.
  • Portfolio Pruning: CHCT sold one property in Q1 and another at year-end 2025, using proceeds to help fund new, higher-yielding acquisitions.
  • Acquisition Discipline: The company acquired a new inpatient rehab facility at a 9.3% cash yield and signed agreements for four more properties totaling $99 million at 9.1-9.75% expected returns.

Dividend growth continued for the 35th consecutive quarter, underscoring management’s confidence in cash flow stability even as the company navigates portfolio transitions and sector headwinds.

Executive Commentary

"Our occupancy decreased from 90.6% to 89.8% during the quarter due to lease terminations. However, our leasing team is very busy with renewals and new leasing activity, and we expect leased occupancy to grow next quarter."

Dave Dupuy, Chief Executive Officer

"We did not issue any shares under our ATM last quarter. However, we continue to evaluate capital recycling opportunities and we would anticipate having sufficient capital from selected asset sales, coupled with our revolver availability, to fund near-term acquisitions."

Dave Dupuy, Chief Executive Officer

Strategic Positioning

1. Capital Recycling as Growth Engine

CHCT is prioritizing asset sales in less attractive markets, using proceeds to self-fund acquisitions of higher-yielding, long-duration assets. The company sold five properties in 2025 and another in early 2026, signaling a methodical shift toward portfolio quality over sheer asset count.

2. Acquisition Pipeline Anchored in Yield and Duration

Signed agreements for $99 million in new properties, all with anticipated cash yields above 9% and 2% annual rent escalators, position CHCT to enhance both near-term cash flow and long-term rent growth. New leases are structured for multi-decade terms, locking in stability.

3. Redevelopment and Tenant Upgrades

Three major redevelopment projects are underway, including a behavioral health facility set to drive incremental NOI starting in Q3 2026. These investments reflect a commitment to tenant quality and asset modernization, which should support occupancy and rental rate resilience.

4. Conservative Leverage and Capital Allocation

Management is avoiding equity issuance at current valuations, favoring internal capital recycling and revolver draws to fund growth. This stance preserves shareholder value and positions the company to act opportunistically as acquisition opportunities arise.

5. Tenant and Market Focus

CHCT continues to target healthcare operators with strong credit and long-term growth prospects, remaining selective in both tenant mix and geographic exposure. The company is leveraging its reputation and relationships to source off-market deals with favorable economics.

Key Considerations

CHCT’s Q1 underscores a deliberate pivot toward quality and risk management, with leadership emphasizing long-term value creation over rapid expansion. The following considerations frame the company’s current position and strategic trajectory:

Key Considerations:

  • Asset Quality Over Quantity: Portfolio pruning and selective acquisitions raise the bar for new investments and future growth.
  • Balance Sheet Flexibility: Sufficient liquidity from asset sales and revolver capacity supports near-term deals without dilutive equity issuance.
  • Sector Competition and Valuation Discipline: Management is resisting the urge to chase crowded senior housing or MOB segments, focusing instead on sustainable yields and tenant quality.
  • Dividend Growth Commitment: Ongoing quarterly dividend increases reinforce management’s confidence in cash flow and signal stability to income-focused investors.

Risks

CHCT faces several risks as it executes its capital recycling and acquisition strategy: Occupancy pressures could persist if leasing velocity slows or redevelopment timelines slip, while rising interest expense from hedge expirations and new borrowings could pressure FFO growth. Sector competition for high-quality healthcare assets remains intense, potentially impacting acquisition yields and pipeline visibility. Regulatory delays, such as those affecting the behavioral hospital transaction, also introduce timing uncertainty.

Forward Outlook

For Q2 2026, CHCT expects:

  • Occupancy to rebound as leasing activity and redevelopments ramp up
  • Interest expense to increase due to higher revolver borrowings and hedge expirations

For full-year 2026, management maintained its disciplined approach:

  • Focus on capital recycling to fund $99 million of acquisitions at 9%+ yields

Management highlighted several factors that will shape results:

  • Timing of redevelopment project completions and lease commencements
  • Progress on the behavioral hospital sale and new lease agreements

Takeaways

CHCT’s Q1 results reflect a measured, quality-first approach to growth, with asset sales and disciplined acquisitions setting the stage for improved portfolio performance in the second half of 2026.

  • Capital Recycling Drives Self-Funded Growth: Asset sales are being used to upgrade the portfolio and avoid dilutive equity issuance, supporting higher long-term returns.
  • Redevelopment and Leasing Momentum: Upcoming project completions and active leasing are expected to reverse Q1 occupancy softness.
  • Watch for Execution on Pipeline and NOI Ramp: Investor focus should remain on the pace of acquisitions, lease-up of redeveloped assets, and stabilization of interest expense as hedges roll off.

Conclusion

CHCT is navigating a competitive healthcare real estate landscape with a disciplined, internally funded expansion strategy, prioritizing asset quality and tenant strength over rapid portfolio growth. Execution on the $99 million pipeline and redevelopment projects will be critical for delivering the anticipated AFFO and dividend growth in the back half of 2026.

Industry Read-Through

CHCT’s capital recycling and yield-focused acquisition strategy highlight a broader trend among healthcare REITs—with sector players increasingly favoring internal capital sources and disciplined underwriting over aggressive expansion. Competition for senior housing and medical office assets remains intense, pushing some operators to prune portfolios and redeploy capital into higher-yielding, less crowded segments such as behavioral health and rehab facilities. Investors should monitor how rising interest rates, regulatory headwinds, and tenant credit quality shape acquisition economics and portfolio resilience across the healthcare REIT sector.